Background Image
Table of Contents Table of Contents
Previous Page  52 / 92 Next Page
Information
Show Menu
Previous Page 52 / 92 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 4, July/August 2016

254

AFRICA

Themeandurationof HAARTmedicationfortheHIV-positive

patients on HAART was 4.0

±

2.4 years, with minimum and

maximum durations of one and 10 years, respectively. Of these

patients, 7% took the HAART regimen containing protease

inhibitors (PIs), while 93% took HAART that did not contain

PIs. However, those on PIs received it for less than six months.

Table 4 shows ECG abnormalities in the study groups and

controls. T-wave inversion (

<

3 mm) in leads V1–V3 (anterior

leads) was the commonest abnormality in all study groups. It

was seen in 44 (65.7%) of the HIV-positive subjects on HAART,

22 (45.8%) of the HIV-positive HAART-naïve subjects and 14

(29.2%) of the controls. T-wave inversion (

<

3 mm) in leads

II, III and aVF (inferior leads) was also seen in two (2.2%)

HIV-positive subjects on HAART, one (1.4%) HIV-positive

HAART-naïve subject, and six (15.8%) control subjects.

Left-axis deviation (LAD), that is, QRS axis of

<

0° to

90°, was seen in 15 (16%) of the HIV subjects on HAART, 10

(13.7%) of the HAART-naïve subjects and eight (21%) of the

controls. First-degree heart block (PR interval

>

0.2 s) was seen

in three (3.2%) HIV-positive subjects on HAART, one (2.1%)

HIV-positive HAART-naïve subject, and two (5.3%) control

subjects.

One (1.1%) subject with low QRS-wave voltage complex

(amplitude of QRS complex

<

5 mm in limb leads or

>

10 mm

in precordial leads), left bundle branch block (LBBB), and right

bundle branch block (RBBB), respectively, was found in the

group of HIV-positive subjects on HAART, while eight (11%)

subjects with left ventricular hypertrophy (LVH) and two (2.7%)

with ST-segment elevation were found among the HIV-positive

HAART-naïve subjects.

Sinus tachycardia (heart rate

>

100 beats per minute) was

seen in eight (8.6%) HIV-positive subjects on HAART, and 14

(19.2%) control subjects, while sinus bradycardia (heart rate

<

60 beats per minute) was seen in only two (5.3%) of the control

subjects. Prolonged QTc (QTc

>

0.44 in males or

>

0.46 in

females) was seen in 17 (18.2%) of the HIV-positive patients on

HAART, 12 (16.4%) of the HIV-positive HAART-naïve patients

and four (10.5%) of the control subjects.

Discussion

The prevalence of ECG abnormalities was higher among

HIV-positive patients on HAART (93%) and HIV-positive

HAART-naïve patients (73%), compared to the controls

(38%) (Table 4). Okoye

19

found a similar prevalence of ECG

abnormalities in 80% of AIDS patients with CD4 cell counts

<

200 cells/mm

3

, 60% of HIV-positive subjects with CD4 cell

counts

>

200 cells/mm

3

and 35% of HIV-negative healthy controls.

The prevalence of ECG abnormalities found in both

HIV-positive patients on HAART and HIV-positive HAART-

naïve patients in this study also compared favourably with the rate

of 86% reported by Mouanodji

et al.

20

Conversely, the prevalence

of ECG abnormalities in this study was significantly higher than

the 53% found by Levy

et al

.

21

and the 55% documented by Herst

et al

.

22

The difference may have been due to the small sample sizes

of 32 and 21 patients in the studies done by Levy

et al

. and Herst

et al

., respectively. Also, not matching the numbers in the study

groups, as well as inclusion of patients at advanced stages of

AIDS by Levy

et al

. could have been reasons for the discrepancy.

LAD, T-wave inversion in leads V1–V3 and prolonged QTc

were the three most common ECG abnormalities found in

HIV-positive patients on HAART and HIV-positive HAART-

naïve patients, respectively, in this study (Table 4). LAD and

T-wave inversion in leads II, III, avF and V1–V3 were the three

most common ECG abnormalities in the controls. LAD was

found more often in both HIV-positive patients on HAART

and HIV-positive HAART-naïve patients than in the control

subjects. T-wave inversion in leads V1–V3 was the commonest

ECG abnormality in all the groups, occurring in 47% of the

HIV-positive patients on HAART, 30.4% of the HIV-positive

HAART-naïve patients and 36.8% of the controls. It also

occurred in smaller proportions in leads II, III, avF, I and

avL. T-wave inversion may signify ischaemia but is often a

non-specific finding, especially in women.

23

No relationship

between ECG abnormalities and gender was found in the study.

ECG evidence of asymptomatic ischaemic heart disease

(IHD) (Q wave or ST-segment depression) was not found in

Table 3. Age distribution in the study groups

Age

(years)

HIV-positive on

HAART,

n

(%)

HIV-positive

HAART-naïve,

n

(%)

HIV-negative

control,

n

(%)

Total,

n

(%)

<

26

11 (23.9)

19 (41.3)

16 (34.8)

46 (100)

26–30

22 (37.9)

19 (32.8)

17 (29.3)

58 (100)

31–35

21 (30.0)

24 (34.3)

25 (35.7)

70 (100)

36–40

17 (35.4)

16 (33.3)

15 (31.3)

48 (100)

41–45

13 (46.4)

7 (25.0)

8 (28.6)

28 (100)

46–50

9 (31.0)

9 (31.0)

11 (37.9)

29 (100)

>

50

7 (33.3)

6 (28.6)

8 (38.1)

21 (100)

Total

100 (33.3)

100 (33.3)

100 (33.3)

300 (100)

χ

2

=

4.739,

p

=

0.192. HIV

=

human immunodeficiency virus; HAART

=

highly

active antiretroviral therapy.

Table 4. ECG abnormalities in the study population

ECG abnormalities

HIV-

positive on

HAART,

n

(%)

HIV-

positive

HAART

naïve,

n

(%)

Control,

n

(%)

χ

2

p

-value

LAD

15 (16)

10 (13.7)

8 (21)

2.656 0.265

T wave inversion in

leads V1 –V3

44 (47)

22 (30.4)

14 (36.8)

24.682

<

0.001

Low QRS voltage

complex

1 (1.1)

0 (0)

0 (0)

2.007 0.367

1st-degree heart block 3 (3.2)

1 (1.4)

2 (5.3)

1.020 0.600

T-wave inversion in

leads II, III, aVF

(inferior leads)

2 (2.2)

1 (1.4)

6 (15.8)

4.811 0.090

VEB

1 (1.1)

1 (1.4)

0 (0)

2.007 0.367

T-wave inversion in

leads I, aVL,V5–V6

(lateral leads)

0 (0)

2 (2.7)

2 (5.3)

2.027 0.363

LBBB

1 (1.1)

0 (0)

0 (0)

2.007 0.367

RBBB

1 (1.1)

0 (0)

2 (5.3)

2.020 0.364

LVH

0 (0)

8 (11)

0 (0)

16.438

<

0.001

Sinus tachycardia

8(8.6)

14 (19.2)

0 (0)

2.020 0.364

ST-segment elevation 0 (0)

2 (2.7)

0 (0)

4.027 0.134

Sinus bradycardia

0 (0)

0 (0)

2 (5.3)

25.000

<

0.001

Mean QTc

±

SD 0.42

±

0.04 0.41

±

0.04 0.39

±

0.03 *15.779

<

0.001

Prolonged QTc

17 (18.2)

12 (16.4)

4 (10.5)

8.784 0.012

Total

93 (100)

73 (100)

38 (100)

*

F

-value. For QTc,

F

=

15.779;

p

<

0.001. Duncan

post hoc

multiple comparison

test showed all significantly different.

LAD

=

left axis deviation, VEB

=

ventricular ectopic beat, LBBB

=

left bundle

branch block, RBBB

=

right bundle branch block, LVH

=

left ventricular hyper-

trophy.